Statistics for Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206
Total visits
views | |
---|---|
Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206 | 225 |
Total visits per month
views | |
---|---|
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 1 |
February 2025 | 0 |
File Visits
views | |
---|---|
Adra_2018_phase.pdf | 268 |
java.util.UUID:80ac20d7-67d0-4c80-9c09-6e0e187e2156 | 57 |
java.util.UUID:547e1722-c562-4f35-b2ee-4888400b2d55 | 9 |
java.util.UUID:a3f0f980-b4ba-4875-af01-e4fcd7443bed | 1 |
Top country views
views | |
---|---|
United States | 175 |
Germany | 8 |
Ukraine | 5 |
Canada | 2 |
China | 2 |
Russia | 2 |
Australia | 1 |
United Kingdom | 1 |
Italy | 1 |
Malaysia | 1 |
Top city views
views | |
---|---|
Wilmington | 52 |
Fairfield | 23 |
Houston | 13 |
Cambridge | 12 |
Jacksonville | 7 |
Kiez | 7 |
Ann Arbor | 6 |
Kiev | 5 |
Lake Mary | 3 |
Seattle | 3 |
White Plains | 3 |
Shenzhen | 2 |
Toronto | 2 |
Washington | 2 |
Augusta | 1 |
Baltimore | 1 |
Bloomington | 1 |
Gunzenhausen | 1 |
Moscow | 1 |
Naples | 1 |
New York | 1 |
Norwalk | 1 |
Palm Harbor | 1 |
Philadelphia | 1 |
Providence | 1 |
Saint Petersburg | 1 |
San Francisco | 1 |
Scottsdale | 1 |
Seremban | 1 |
Wallacia | 1 |